By Angelica Stabile
Published 2 days ago
FOX Business
https://www.fox6now.com/sports/nfl-legend-brett-favre-invests-in-concussion-treatment-meant-to-cure-cte
WASHINGTON - Professional football’s concussion crisis could be turning around as NFL Hall of Famer Brett Favre has backed a promising preventative treatment for head injuries.
The former Green Bay Packers quarterback told FOX Business’ "Kennedy" on Monday he’s an investor in pharmaceutical company Prevacus, which is developing a concussion medication called Prevasol, which could be the first step to preventing CTE.
"Concussions are going to happen, regardless of how good the helmets are," Favre explained. "Spending more resources and time on prevention, rather than some type of treatment, is where [the NFL is] lacking."
Prevacus president and founder Dr. Jacob Vanlandingham joined the conversation to explain how Prevasol works. He said the treatment is to be used directly after a concussion occurs to limit long-term damage.
The drug, taken via nasal spray, reportedly helps repair nerves and promotes cell growth, and has entered phase one of human trials. Vanlandingham explained that Prevasol is considered a "neuro-steroid" that penetrates the blood-brain barrier "relatively quickly."
"We can get the drug in the brain in less than five minutes," he said. "And our plan is, when we get that diagnosis on the field of play, give the drug nasally, get it in the brain quickly."
Once the drug enters the nucleus of the brain, Vanlandingham added, it reduces swelling, inflammation and oxidative stress simultaneously. The doctor expects phase one trials to wrap up this year.
Prevacus has recently been acquired by Odyssey Group International – traded publicly under ODYY – which allowed the company financial liberty to conduct trials.
Recent ODYY News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/14/2024 09:10:28 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM